<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Sanofi Anticoagulants Morpholines Rivaroxaban Thiophenes Clopidogrel Acute coronary syndrome Antiplatelet drug Organic chemistry Chemistry Medicine |
| PDF DocumentDocID: 1vWaT - View Document |
| Press release Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi DocID: 1vq21 - View Document |
| Press release Ipsen completes acquisition of select Consumer Healthcare products from Sanofi Paris (France), 8 May 2017 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has completed its previously announceDocID: 1vnbG - View Document |
| SANOFI WELCOMES House Policy Coucus KEY FACTS & FIGURES sANoFtDocID: 1v7jN - View Document |
| A GLOBAL HEALTHCARE COMPANY We are Sanofi CORPORATE PRESENTATION | JUNEDocID: 1uQ20 - View Document |